Analyst Ratings for Sagimet Biosciences Inc (SGMT)
SGMT Rating Summary
SGMT Price Target Summary
- Highest: $56.00 (Canaccord)
- Lowest: $7.00 (Goldman Sachs)
- Average: $28.90
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$28.90 (+260.3%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Rating Score: 9.4 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/24/2026 | Goldman Sachs | Andrea Newkirk | New Coverage | Sell (N/A) |
7.00 (N/A) |
11.09 (8.02) |
-27.68% | Details |
| 9/9/2026 | Cantor Fitzgerald » Updated 10/1/2026 |
Yanni Souroutzidis | New Coverage | Overweight (N/A) |
N/A (N/A) |
10.71 (8.02) |
-25.12% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||



